{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T05:22:22Z","timestamp":1738387342416,"version":"3.35.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,31]]},"DOI":"10.7759\/cureus.78284","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T13:24:51Z","timestamp":1738329891000},"source":"Crossref","is-referenced-by-count":0,"title":["Type 2 Respiratory Failure as an Initial Manifestation of Lambert\u2013Eaton Myasthenic Syndrome Complicated by Paraneoplastic Autoimmune Encephalitis"],"prefix":"10.7759","author":[{"given":"Sota","family":"Uemura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Sasada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Kohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michi","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2018.01.008","article-title":"Lambert-Eaton myasthenic syndrome","volume":"36","author":"Kesner VG","year":"2018","unstructured":"Kesner VG, Oh SJ, Dimachkie MM, Barohn RJ. Lambert-Eaton myasthenic syndrome. Neurol Clin. 2018, 36:379-94. 10.1016\/j.ncl.2018.01.008","journal-title":"Neurol Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00083-2","article-title":"Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease","volume":"22","author":"Dalmau J","year":"2023","unstructured":"Dalmau J, Graus F. Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease. Lancet Neurol. 2023, 22:529-40. 10.1016\/S1474-4422(23)00083-2","journal-title":"Lancet Neurol"},{"key":"ref3","article-title":"A case of combined paraneoplastic neurological syndrome, with Lambert-Eaton myasthenic syndrome manifesting as severe respiratory failure, and anti-Hu syndrome (Article in Japanese)","volume":"41","author":"Sugie M","year":"2001","unstructured":"Sugie M, Yanagimoto S, Mori K, Ueno S. A case of combined paraneoplastic neurological syndrome, with Lambert-Eaton myasthenic syndrome manifesting as severe respiratory failure, and anti-Hu syndrome (Article in Japanese). Rinsho Shinkeigaku. 2001, 41:418-22.","journal-title":"Rinsho Shinkeigaku"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2020.03.88","article-title":"Paraneoplastic syndromes in small cell lung cancer","volume":"12","author":"Soomro Z","year":"2020","unstructured":"Soomro Z, Youssef M, Yust-Katz S, Jalali A, Patel AJ, Mandel J. Paraneoplastic syndromes in small cell lung cancer. J Thorac Dis. 2020, 12:6253-63. 10.21037\/jtd.2020.03.88","journal-title":"J Thorac Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0000000000000192","article-title":"Paraneoplastic Lambert-Eaton myasthenic syndrome with Limbic encephalitis: clinical correlation with the coexistence of anti-VGCC and anti-GABAB receptor antibodies","volume":"19","author":"Cho JJ","year":"2017","unstructured":"Cho JJ, Wymer JP. Paraneoplastic Lambert-Eaton myasthenic syndrome with Limbic encephalitis: clinical correlation with the coexistence of anti-VGCC and anti-GABAB receptor antibodies. J Clin Neuromuscul Dis. 2017, 19:84-8. 10.1097\/CND.0000000000000192","journal-title":"J Clin Neuromuscul Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010696","article-title":"Coexistence of Lambert-Eaton myasthenic syndrome and autoimmune encephalitis with anti-CRMP5\/CV2 and anti-GABAB receptor antibodies in small cell lung cancer: a case report","volume":"97","author":"Li H","year":"2018","unstructured":"Li H, Zhang A, Hao Y, Guan H, Lv Z. Coexistence of Lambert-Eaton myasthenic syndrome and autoimmune encephalitis with anti-CRMP5\/CV2 and anti-GABAB receptor antibodies in small cell lung cancer: a case report. Medicine (Baltimore). 2018, 97:0696. 10.1097\/MD.0000000000010696","journal-title":"Medicine (Baltimore)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.2569-23","article-title":"Lambert-Eaton myasthenic syndrome complicated by anti-GABA(B) receptor encephalitis","volume":"63","author":"Yamada K","year":"2024","unstructured":"Yamada K, Yaguchi H, Ishikawa K, et al.. Lambert-Eaton myasthenic syndrome complicated by anti-GABA(B) receptor encephalitis. Intern Med. 2024, 63:1295-300. 10.2169\/internalmedicine.2569-23","journal-title":"Intern Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/335927-type-2-respiratory-failure-as-an-initial-manifestation-of-lambert-eaton-myasthenic-syndrome-complicated-by-paraneoplastic-autoimmune-encephalitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T13:24:52Z","timestamp":1738329892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/335927-type-2-respiratory-failure-as-an-initial-manifestation-of-lambert-eaton-myasthenic-syndrome-complicated-by-paraneoplastic-autoimmune-encephalitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.78284","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,31]]}}}